It’s World Lupus Day
Posted by
10-May-2012
<iframe width="100%" height="244"
src="http://www.youtube.com/embed/5_NgvgQYrOY" frameborder="0"
allowfullscreen></iframe>
Today is World Lupus Day, an opportunity to raise awareness of a severe disease which affects between 20 and 70 people per 100,0001 . At UCB, we’re investing in research in an effort to support people with lupus.
Systemic lupus erythematosus (SLE) is a severe chronic autoimmune disease in which body's defence mechanism begins to attack its own healthy organs. It is more common in women than in men. In fact, women of child-bearing age are nine times more likely than men of the same age to develop the disease1 .
Managing symptoms – which include extreme fatigue, headaches, painful joints and fever – is a priority for patients. And it’s a priority for us at UCB.
Our research has led to the development of a monoclonal antibody which is currently in clinical trials and being evaluated as a treatment for lupus.
Reference
1. Pons-Estel GJ, Alarcon GS, Scofield L, et al., Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 2010;39:257-68.
Today is World Lupus Day, an opportunity to raise awareness of a severe disease which affects between 20 and 70 people per 100,0001 . At UCB, we’re investing in research in an effort to support people with lupus.
Systemic lupus erythematosus (SLE) is a severe chronic autoimmune disease in which body's defence mechanism begins to attack its own healthy organs. It is more common in women than in men. In fact, women of child-bearing age are nine times more likely than men of the same age to develop the disease1 .
Managing symptoms – which include extreme fatigue, headaches, painful joints and fever – is a priority for patients. And it’s a priority for us at UCB.
Our research has led to the development of a monoclonal antibody which is currently in clinical trials and being evaluated as a treatment for lupus.
Reference
1. Pons-Estel GJ, Alarcon GS, Scofield L, et al., Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 2010;39:257-68.
Leave a Comment